The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Armenian victims group ask International Criminal Court to investigate genocide claim
China emphasizes neighborly cooperation in diplomacy: NPC spokesman
Senior adviser upbeat about HK's future
NPC reveals agenda legislators will deliberate
Mariska Hargitay is mistaken for real
Sweden ready to complete NATO membership bid
NPC aims to further enhance the legal system
Quentin Tarantino SCRAPS plans for his final film The Movie Critic which had Brad Pitt set to star
Mainland, KMT seek common ground: Promoting exchange, opposing external interference
Princess Amalia of The Netherlands, 20, who fled to Spain for a year after kidnap threats
State secrets law revised to handle online leaks